Prior to becoming Director of the Cancer Clinical Trials division/NCIC Clinical Trials Group on September 1, 2014, Dr. Dancey was Director, Translational Research – Clinical at CTG. She is also Scientific Director of the Canadian Cancer Clinical Trials Network and Director of the High Impact Clinical Trials Program at the Ontario Institute for Cancer Research. Prior to joining the NCIC CTG, Dr. Dancey was Senior Clinical Investigator in the Cancer Therapy Evaluation Program at the US National Cancer Institute and then Associate Chief of the Investigational Drug Branch. Dr. Dancey received her MD from the University of Ottawa and completed her residency training in internal medicine and medical oncology at the University of Toronto. In 1994-95, she was a research fellow with the NCIC CTG and continued her fellowship training at the Institut Gustave Roussy in France. Dr. Dancey has special expertise in new anti-cancer drug development, linking drug and biomarker development, and associated clinical trials methodology. She is also Professor in the Department of Oncology at Queen’s University.